March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

February 26, 2026

‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada

American healthcare workers are making a significant move to Canada, driven by political instability in the U.S. and the allure of a progressive health system.

Conexiant

February 25, 2026

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

Conexiant

February 20, 2026

COVID Vaccine in Pregnancy: Link to Development? 

Multicenter study finds equivalent ASQ-3 scores at 18–30 months in offspring of vaccinated and unvaccinated mothers

Conexiant

February 18, 2026

Medical Oddities: Essential Oil, Deadly Consequences

A cabinet mix-up, a chatty heart, a violet catheter bag, stressed kids, and tea that won’t save the brain—just another week.

Conexiant

February 17, 2026

Retinal AI Predicts Neonatal Lung Disease

Retinal scans already performed in the NICU could flag infants at risk for serious lung disease before standard diagnosis

Conexiant

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

February 16, 2026

Omadacycline for Pediatric CAP

Case details intravenous-to-oral strategy after multiple antibiotic hypersensitivity reactions

Conexiant

February 13, 2026

Does Air Pollution Affect Skin Health?

Large systematic review finds consistent associations across conditions but highlights low certainty driven by bias and study heterogeneity.

Conexiant